CFPB to Review Anti-Discrimination Policies and Fair Lending Rules Amid Policy Shift 
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market 
Democrats Face Uphill Battle in Midterm Elections Despite Recent Victories, Reuters/Ipsos Poll Shows 
EU Court Cuts Intel Antitrust Fine to €237 Million Amid Long-Running AMD Dispute 
International Outcry Grows Over Re-Arrest of Nobel Laureate Narges Mohammadi in Iran 
U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance 
Merck Nears Acquisition of Cidara Therapeutics at Significant Premium 
FDA Lifts REMS Requirement for CAR-T Cell Cancer Therapies 
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates 
Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand 
Belarus Pledges to Halt Smuggling Balloons Into Lithuania 
Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman 
SoftBank Shares Slide as Oracle’s AI Spending Plans Fuel Market Jitters 
Microsoft Unveils Massive Global AI Investments, Prioritizing India’s Rapidly Growing Digital Market 
Trump’s Approval of AI Chip Sales to China Triggers Bipartisan National Security Concerns 
Pfizer Sues Novo Nordisk Over Alleged Tactics to Block Obesity Drug Competition 
SpaceX Starship Test Flight Reaches New Heights but Ends in Setback 
U.S. President Donald Trump has signed an executive order aimed at expanding the use of artificial intelligence (AI) in pediatric cancer research. The order provides an additional $50 million in research grants to accelerate progress in finding cures for childhood cancers, according to White House officials.
This move builds on the National Cancer Institute’s (NCI) Childhood Cancer Data Initiative, a decade-long, $500 million program launched in 2019 to collect and share vital data on pediatric cancers. Michael Kratsios, director of the White House Office of Science and Technology Policy, highlighted that childhood cancer remains the leading cause of disease-related deaths among children in the United States, with cases rising more than 40% since 1975.
Kratsios noted that advances in AI can now be harnessed to sharpen diagnoses, improve clinical trials, fine-tune treatment strategies, and enhance prevention methods. Data gathered through the NCI initiative is expected to empower researchers with new tools to tackle the complexity and diversity of pediatric cancers.
In addition to the $50 million in grants, the National Institutes of Health (NIH) will double its commitment by investing another $50 million. This funding aims to attract leading scientific teams through competitive research opportunities. Further investments are also anticipated to strengthen ongoing initiatives.
The announcement comes despite Trump’s 2026 budget proposal, which suggested a 37% cut to the NCI budget. Lawmakers in both the House and Senate, however, have pushed back against these cuts, and budget negotiations remain ongoing.
Globally, the World Health Organization reports that around 400,000 children and adolescents are diagnosed with cancer each year. While advances in adult cancer research have surged with AI, pediatric cancer research has lagged due to challenges like cancer rarity, diversity, and ethical concerns over patient data protection.
By reinforcing funding and leveraging AI, the administration aims to close this gap and accelerate life-saving innovations in childhood cancer treatment.
